Related references
Note: Only part of the references are listed.SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells
Mitsuro Kanda et al.
ONCOGENE (2018)
Wnt is necessary for mesenchymal to epithelial transition in colorectal cancer cells
Renate H. M. Schwab et al.
DEVELOPMENTAL DYNAMICS (2018)
Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer
Mitsuro Kanda et al.
ANNALS OF SURGERY (2018)
FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer
Haruyoshi Tanaka et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Angela M. Krebs et al.
NATURE CELL BIOLOGY (2017)
SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer
Elizabeth M. Hultgren et al.
PLOS ONE (2017)
Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells
Shaqiu Zhang et al.
PLOS ONE (2017)
Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan
Yasuhiro Kodera
SURGERY TODAY (2017)
Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics
Roya Tabatabai et al.
TARGETED ONCOLOGY (2017)
The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation
Yue Song et al.
TUMOR BIOLOGY (2017)
FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells
Takashi Miwa et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer
Mitsuro Kanda et al.
GASTRIC CANCER (2016)
MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer
Teng Ma et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Overexpression of SASH1 Inhibits TGF-β1-Induced EMT in Gastric Cancer Cells
Wei Zong et al.
ONCOLOGY RESEARCH (2016)
SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer
Yingying Cheng et al.
TUMOR BIOLOGY (2016)
Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer
Mitsuro Kanda et al.
ONCOTARGET (2016)
SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance
J. N. Sheets et al.
ONCOGENESIS (2016)
ITGAV and ITGA5 diversely regulate proliferation and adipogenic differentiation of human adipose derived stem cells
E. M. Morandi et al.
SCIENTIFIC REPORTS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The impact of PET/CT on the management of hepatic and extra hepatic metastases from gastrointestinal cancers
Erdal Polat et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer
Cuixia Cai et al.
ONCOLOGY LETTERS (2015)
Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases
T. Kinoshita et al.
BRITISH JOURNAL OF SURGERY (2015)
Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines
Yasuhiro Kodera et al.
GASTRIC CANCER (2014)
Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study
Eu Chang Hwang et al.
BMC UROLOGY (2014)
Multiple Functions of Sushi Domain Containing 2 (SUSD2) in Breast Tumorigenesis
Allison P. Watson et al.
MOLECULAR CANCER RESEARCH (2013)
Frizzled7 as an emerging target for cancer therapy
Taj D. King et al.
CELLULAR SIGNALLING (2012)
The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
Nina Fenouille et al.
PLOS ONE (2012)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Isolation of a novel mouse gene, mSVS-1/SUSD2, reversing tumorigenic phenotypes of cancer cells in vitro
Tetsuo Sugahara et al.
CANCER SCIENCE (2007)
Updates on esophageal and gastric cancers
Amy Gallo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis
Jason J. Christiansen et al.
CANCER RESEARCH (2006)
Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines
SJ Gong et al.
CANCER LETTERS (2004)
Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins
KA Egland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
